Literature DB >> 16206185

Binding characteristics of the 5-HT2A receptor antagonists altanserin and MDL 100907.

Heidi Kristiansen1, Betina Elfving, Per Plenge, Lars H Pinborg, Nic Gillings, Gitte M Knudsen.   

Abstract

To study the 5-HT(2A) receptors in the living human brain, using positron emission tomography (PET), two selective radiotracers are currently in use: [(18)F]altanserin and [(11)C]MDL 100907. It is, however, currently unknown to what extent data obtained with either tracer are directly comparable. The aim of this study was to compare binding characteristics of these two radiotracers in rat brain with respect to affinity (K(d)), receptor binding density (B(max)), binding potential (BP), and nonspecific binding. Further, binding kinetics, sensitivity towards competition with the endogenous transmitter serotonin, and the competitive/noncompetitive interaction between the two radioligands were evaluated. In addition, the selectivity of [(18)F]altanserin for the 5-HT(2A) receptor was assessed. The K(d) value of [(18)F]altanserin and [(3)H]MDL 100907 was in the order of 0.3 nM. B(max) in frontal cortex was 523 and 527 fmol/mg protein, respectively. The binding of [(18)F]altanserin was not influenced by blocking either the 5-HT(2B/2C) or the alpha(1)-adrenergic receptors. At 37 degrees C the association t(1/2) was 2.8 and 2.7 min and the dissociation t(1/2) was 11 and 13.5 min for [(18)F]altanserin and [(3)H]MDL 100907, respectively. Both radioligands were displaced by 5-HT, only at high concentrations; the K(i) value of 5-HT ranging between 650 and 3,300 nM. This indicates that binding of both radioligands in PET studies is not directly influenced by changes in endogenous 5-HT.Overall, the binding of [(18)F]altanserin and [(3)H]MDL 100907 to the 5-HT(2A) receptor was very comparable, showing selective high affinity binding in the subnanomolar range. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16206185     DOI: 10.1002/syn.20205

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  18 in total

1.  The neuropharmacology of prolactin secretion elicited by 3,4-methylenedioxymethamphetamine ("ecstasy"): a concurrent microdialysis and plasma analysis study.

Authors:  K S Murnane; H L Kimmel; K C Rice; L L Howell
Journal:  Horm Behav       Date:  2011-12-14       Impact factor: 3.587

2.  Analysis of 5-HT(2A) receptor binding with [(11)C]MDL 100907 in rats: optimization of kinetic modeling.

Authors:  Anniek K D Visser; Erik F J De Vries; Nisha K Ramakrishnan; Antoon T M Willemsen; Fokko J Bosker; Johan A den Boer; Rudi A J O Dierckx; Aren van Waarde
Journal:  Mol Imaging Biol       Date:  2013-12       Impact factor: 3.488

3.  Radiosynthesis and in vivo evaluation of a series of substituted 11C-phenethylamines as 5-HT (2A) agonist PET tracers.

Authors:  Anders Ettrup; Martin Hansen; Martin A Santini; James Paine; Nic Gillings; Mikael Palner; Szabolcs Lehel; Matthias M Herth; Jacob Madsen; Jesper Kristensen; Mikael Begtrup; Gitte M Knudsen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-12-21       Impact factor: 9.236

4.  Serotonin2A receptor blockade and clinical effect in first-episode schizophrenia patients treated with quetiapine.

Authors:  Hans Rasmussen; Bjorn H Ebdrup; David Erritzoe; Bodil Aggernaes; Bob Oranje; Jan Kalbitzer; Lars H Pinborg; William F C Baaré; Claus Svarer; Henrik Lublin; Gitte M Knudsen; Birte Glenthoj
Journal:  Psychopharmacology (Berl)       Date:  2010-07-08       Impact factor: 4.530

Review 5.  A review of the literature on neuroimaging of serotoninergic function in Alzheimer's disease and related disorders.

Authors:  E Salmon
Journal:  J Neural Transm (Vienna)       Date:  2007-02-19       Impact factor: 3.575

6.  Extended characterisation of the serotonin 2A (5-HT2A) receptor-selective PET radiotracer 11C-MDL100907 in humans: quantitative analysis, test-retest reproducibility, and vulnerability to endogenous 5-HT tone.

Authors:  Peter S Talbot; Mark Slifstein; Dah-Ren Hwang; Yiyun Huang; Erica Scher; Anissa Abi-Dargham; Marc Laruelle
Journal:  Neuroimage       Date:  2011-07-18       Impact factor: 6.556

7.  Sustained recreational use of ecstasy is associated with altered pre and postsynaptic markers of serotonin transmission in neocortical areas: a PET study with [¹¹C]DASB and [¹¹C]MDL 100907.

Authors:  Nina Bl Urban; Ragy R Girgis; Peter S Talbot; Lawrence S Kegeles; X Xu; W Gordon Frankle; Carl L Hart; Mark Slifstein; Anissa Abi-Dargham; Marc Laruelle
Journal:  Neuropsychopharmacology       Date:  2012-02-22       Impact factor: 7.853

8.  Suitability of [18F]altanserin and PET to determine 5-HT2A receptor availability in the rat brain: in vivo and in vitro validation of invasive and non-invasive kinetic models.

Authors:  Tina Kroll; David Elmenhorst; Andreas Matusch; Franziska Wedekind; Angela Weisshaupt; Simone Beer; Andreas Bauer
Journal:  Mol Imaging Biol       Date:  2013-03-01       Impact factor: 3.488

9.  Effect of cyclosporin A administration on the biodistribution and multipinhole muSPECT imaging of [123I]R91150 in rodent brain.

Authors:  P Blanckaert; I Burvenich; S Staelens; S De Bruyne; L Moerman; L Wyffels; F De Vos
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-11-05       Impact factor: 9.236

10.  Acute S-ketamine application does not alter cerebral [18F]altanserin binding: a pilot PET study in humans.

Authors:  A Matusch; R Hurlemann; E Rota Kops; O H Winz; D Elmenhorst; H Herzog; K Zilles; A Bauer
Journal:  J Neural Transm (Vienna)       Date:  2007-06-01       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.